The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / September / Synthetic DNA Expands the Genetic Alphabet
Biochemistry and molecular biology Genetics and epigenetics Technology and innovation Research and Innovations

Synthetic DNA Expands the Genetic Alphabet

Researchers identify the structural basis of eight-letter genetic transcription

09/29/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Report: Synthetic DNA Expands the Genetic Alphabet

Overview

This study demonstrates that Escherichia coli RNA polymerase can transcribe an expanded genetic alphabet with eight nucleotide letters, including four synthetic bases. The research identifies methods to reduce transcription errors associated with one of the synthetic bases, Z.

Background

The ability to expand the genetic alphabet has implications for synthetic biology and genetic engineering. By incorporating synthetic bases, researchers can create nucleic acids with properties that natural DNA and RNA do not possess.

Data Highlights

No numerical data or trial data presented.

Key Findings

  • Escherichia coli RNA polymerase can efficiently transcribe an eight-letter genetic alphabet.
  • The synthetic bases P, Z, B, and S form two additional pairs: P:Z and B:S.
  • The incorporation rate of the synthetic pair P:Z is approximately twofold lower than that of the natural guanine-cytosine pair.
  • Errors in pairing were linked to the chemical structure of base Z, which can change under physiologic pH.
  • A modified base, Z*, significantly reduced incorrect pairing with guanine while maintaining pairing with P.
  • Cryo-electron microscopy revealed that synthetic bases fit into the enzyme’s active site similarly to natural base pairs.

Clinical Implications

Further research is needed to establish the reliability of this expanded genetic system in living cells.

Conclusion

This research enhances the understanding of how biological systems can accommodate synthetic genetic material.

Related Resources & Content

  1. Nature Communications, 2026 -- Structural basis of transcription of the hachimoji eight-letter alphabet by E. coli RNA polymerase
  2. PMC, 2024 -- Genetic Code Engineering by Natural and Unnatural Base Pair Systems for the Site-Specific Incorporation of Non-Standard Amino Acids Into Proteins
  3. FDA -- Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application
  4. the medicine maker — Complex DNA; No Compromises
  5. the analytical scientist — Digital Versatile DNA
  6. the pathologist — New Meta-DNA Structures for DNA Origami
  7. the medicine maker — Immune-Stealth DNA Enables Safer, Large-Scale Genome Writing
  8. Complex DNA; No Compromises
  9. Digital Versatile DNA
  10. New Meta-DNA Structures for DNA Origami
  11. Structural basis of transcription of the hachimoji eight-letter alphabet by E. coli RNA polymerase | Nature Communications
  12. Genetic Code Engineering by Natural and Unnatural Base Pair Systems for the Site-Specific Incorporation of Non-Standard Amino Acids Into Proteins - PMC
  13. Chemistry, Manufacturing, and Controls Flexibilities for Developing Human Cellular and Gene Therapy Products for a Biologics License Application | FDA

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.